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Abstract
p16INK4A (p16) binds to cyclin-dependent kinase 4/6
and negatively regulates cell growth. Recent studies
have led to an understanding of additional biologic
functions for p16; however, the detailed mechanisms
involved are still elusive. In this article, we show an un-
expected expression of anion exchanger 1 (AE1) in the
cytoplasm in poorly and moderately differentiated gas-
tric and colonic adenocarcinoma cells and in its inter-
action with p16, thereby sequestrating the protein in the
cytoplasm. Genetic alterations of p16 and AE1 were not
detectable. Forced expression of AE1 in these cells
sequestrated more p16 in the cytoplasm, whereas small
interfering RNA–mediated silencing of AE1 in the cells
induced the release of p16 from the cytoplasm to the
nucleus, leading to cell death and growth inhibition of
tumor cells. By analyzing tissue samples obtained from
patients with gastric and colonic cancers, we found that
83.33% of gastric cancers and 56.52% of colonic can-
cers coexpressed AE1 and p16 in the cytoplasm. We
conclude that AE1 plays a crucial role in the pathogen-
esis of gastric and colonic adenocarcinoma and that p16
dysfunction is a novel pathway of carcinogenesis.
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Introduction
Prior research has demonstrated that p16 expression is
associated with cell-cycle arrest at G1 checkpoint [1,2].
Several factors are involved in the mechanism of the func-
tional inactivation of p16 in human malignancies, such as
homozygous deletions, intragenic mutations, and transcrip-
tional silencing due to promoter hypermethylation [3–5].
Hence, expression of p16 has been proposed as a bio-
marker for the identification of cancer.
Apart from cell-cycle control, a number of studies have
led to a better understanding of additional biologic functions
for p16 [6–8]. The molecular basis for the regulation of ex-
pression, function, and localization in subfractions remains
poorly understood, although regulation is important for under-
standing the physiological and pathophysiological significance
of p16. Our previous work has shown that there are direct inter-
action and functional synergy between p16 and anion exchanger
1 (AE1) [9].
Human AE is a transmembrane protein that facilitates the
electroneutral exchange of Cl and HCO3
 across the plasma
membrane. To date, three different genes, AE1, AE2, and AE3,
have been identified. Each of these genes encodes for a dif-
ferent polypeptide, depending on splicing and transcription
initiation site [10,11]. AE proteins can be divided into three
distinct domains: 1) an N-terminal cytoplasmic domain; 2) a
C-terminal membrane-spanning domain of 500 amino acids com-
prising 14 helices; and 3) an acidic, short C-terminal domain
(f 40 amino acids) in the cytoplasm. The isoforms differ pri-
marily in their cytoplasmic and membrane-spanning domains,
but show great similarities in their role in anion translocation
through the plasma membrane [12,13].
AE1 has been shown to be a unique AE member that is
abundantly expressed in erythrocytes. The protein makes up
25% of the total erythrocyte membrane protein, and up to 50%
of the intrinsic membrane protein. Its N-terminal– truncated
variant is expressed in renal cortical and medullary collecting
ducts, which lacks N-terminal [65 (human) or 79 (mouse)]
amino acid residues of erythrocyte AE1 (kAE1) [14,15]. AE2
is primarily expressed in gastric mucosa, choroid plexus, and
intestine [16,17]. Although mRNA transcripts have been re-
ported for AE1 in spleen, heart, lungs, and liver, the actual
protein remains undetectable, except in erythrocytes [18]. In
this study, we report that AE1 protein is abundantly expressed
in gastric and colonic cancer tissues and is closely related to
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human gastric and colonic carcinogenesis due to p16 se-
questration in the cytoplasm.
Materials and Methods
Cell Lines
The following cell lines were used: human chronic myeloid
leukemic cell line K562; hepatoma cell line HepG2; human
pancreatic cancer cell line Patu8988; human breast cancer
cell line T47D; human gastric adenocarcinoma cell lines
MKN45, MKN28, SGC7901, and AGS; and colon adenocar-
cinoma cell line SW1116 (Cell Bank of Shanghai Institutes
for Biological Sciences, Shanghai, China).
Cell Fractionation
For fractionations of the nucleus and cytoplasm, 1  107
cells were incubated in 400 ml of lysis buffer for 10 minutes,
then supplemented with NP-40 and protease inhibitor cock-
tail (Sigma, St. Louis, MO) for 1 minute on ice. Lysates were
centrifuged for 1 minute at 2300g. Supernatants were col-
lected for cytoplasmic protein extracts. Pellets were washed
with lysis buffer without NP-40, resuspended in 150 ml of
extraction buffer, and incubated for 20 minutes on ice. The
samples were centrifuged at 12,000g for 10 minutes, and the
supernatants were collected as nuclear protein extracts.
Coimmunoprecipitation of Endogenous p16 and AE1 in
MKN45 and SW1116 Cells
After ultrasonic vibration, cell samples were cleared of
insoluble debris by centrifugation for 15 minutes at 10,000g
and were incubated with anti-AE1 (Sigma) or p16 (Santa
Cruz Biotechnology, Santa Cruz, CA) antibodies and protein
A-Sepharose beads (Amersham Biosciences, Piscataway,
NJ) overnight on a rotator at 4jC. The protein A-Sepharose
beads were washed thrice with lysis buffer and quenched
with 35 ml of SDS sample buffer. Coimmunoprecipitates were
resolved by 9% SDS-PAGE and analyzed by Western blot
analysis.
Immunocytochemistry
For endogenous AE1 and AE2, MKN45 and SW1116
cells were grown on glass coverslips, and the proteins were
detected with anti-AE1 or anti-AE2 antibodies (Alpha Diag-
nostics International, San Antonio, TX). Secondary anti-AE1
antibody was coupled to Texas red, and anti-AE2 antibody
was coupled to fluorescein isothiocyanate. Coverslips were
then mounted on slides and inspected with a fluorescence
microscope.
siRNA Vector Construction and Transfections
Three-target sequences of siRNA were selected: P1, 5V-
GGG TAC TGT TCT CCT AGA C-3V; P2, 5V-CGG TCT AGA
GTA CAT CGT G-3V; and P3, 5V-GGC AAC CTT TGA TGA
GGA G-3V. These sequences were synthesized and inserted
into the pSilencer 3.1-H1 neo vector in accordance with the
manufacturer’s instructions (Ambion, Austin, TX). For stable
transfection, cells were transfected with P2 vector or scram-
bled vector and placed under G418 selection for 4 weeks.
Surviving colonies were isolated and expanded.
Western Blot Analysis
Cell lysates or tissue protein extracts were equally loaded
into an 8% acrylamide gel, electrophoresed, and transferred
to nitrocellulose membranes. After blocking with 5% nonfat
milk in PBS, the membranes were probed with mouse mono-
clonal anti-AE1 antibody (Sigma) or rabbit polyclonal anti-
p16 (Santa Cruz Biotechnology), followed by horseradish
peroxidase– linked secondary antibodies (Cell Signaling,
Danvers, MA).
Immunohistochemistry
For paraffin sections, human tissues were fixed with 4%
paraformaldehyde in 0.1 M cacodylate buffer and postfixed in
a similar fixative, with the exception that 3% paraformalde-
hyde was used in a 1-hour postfixation. The use of human
tissues had prior approval of the National Ethical Committee.
Paraffin-embedded tissue sections were dewaxed in xylene
and rehydrated with ethanol. After a 30-minute incubation in
0.3% H2O2 in methanol to block endogenous peroxidase ac-
tivity, rehydration was completed with ethanol. Sections were
incubated overnight at 4jC with anti-AE1 and anti-p16 anti-
bodies diluted in 10 mM PBS (pH 7.4) containing 0.1% Triton
X-100 and 0.1% BSA.
Results
Two Gastrointestinal Cancer Cells Abnormally Expressed
Cytoplasmic AE1 and p16
All cell lines tested normally express AE2 protein. How-
ever, the gastrointestinal tumor cell lines MKN45 and SW1116
unconventionally expressed AE1 protein, which is absent in
normal gastric or colonic tissue. Because of the interaction of
AE1 with p16, as we have previously reported [9], we subse-
quently investigated the expression of p16 protein in these
cells. Western blot analysis showed that p16 is expressed in
the cytoplasm in MKN45 and SW1116 cells and is absent in
the other four cell lines (Figure 1A). Investigation of p16 local-
ization in cellular subfractions indicated that p16 protein is
not expressed in the nucleus, but largely in the cytoplasm of
MKN45 and SW1116 cells (Figure 1B). We thus proceeded to
analyze the localization of AE1 and AE2 proteins in the two
cell lines with an immunofluorescent assay. Unlike AE2 pro-
tein, which is normally localized on cell plasma membrane,
AE1 had no expression on the cell surface of the cell lines, but
was diffuse within the cytoplasm (Figure 1C).
In the next phase of the analysis, 66 paraffin-embedded
human gastric cancer samples and 27 colonic cancer sam-
ples were assessed for the expression of AE1 and p16 pro-
teins in parallel with normal human tissue control samples.
Fifty-five of 66 cases of gastric cancer, and 15 of 27 cases of
colonic cancer positively stained for AE1, which was distrib-
uted in the cytoplasm in different grades, and p16 was also
stained in the cytoplasm in those samples. A typical staining
of AE1 (a and c) and p16 (b and d ) in human gastric
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noncancer (a and b) and adenocarcinoma (c and d ) tissues
is shown in Figure 1D. In contrast to cancer tissues, non-
cancer human gastric and colonic (data not shown) tissues
stained negative for AE1 and the nuclear expression of p16.
Immunoreactivities of whole-tissue specimens were semi-
quantified independently by two individuals into four de-
grees (0 = none, 1 = mild, 2 = moderate, 3 = abundant,
and 4 = strong). The correlation of expression of AE1 with
p16 was statistically analyzed using Pearson’s correlation
coefficient (Table 1). Together, the results strongly support
the notion that AE1 expression in gastric and colonic ade-
nocarcinoma is closely related to the cytoplasmic expression
of p16 (gastric cancer AE1 vs cytoplasmic p16, r = 0.93; co-
lonic cancer AE1 vs cytoplasmic p16, r = 0.99).
AE1 and p16 Proteins Interacted with Each Other in MKN45
and SW1116 Cells
To investigate whether endogenous AE1 and p16 proteins
interacted with each other in MKN45 and SW1116 cells, a co-
immunoprecipitation (Co-IP) experiment was carried out. As
shown in Figure 2, anti-AE1 and anti-p16 antibodies, but not
preimmune mouse serum, could precipitate both AE1 and
p16, indicating the specificity of the Co-IP experiment. More
importantly, anti-AE1 coprecipitated p16 protein, whereas anti-
p16 antibody precipitated AE1 protein, strongly confirming
the interaction of AE1 and p16 proteins in the two tumor cells.
Distribution of p16 in Cellular Subfractions Was Not
pH-Dependent
Both AE1 and AE2 facilitated Cl and HCO3
 exchange
and regulated cellular pH homeostasis in cells in which they
were abundantly expressed. We reasoned that aberrant
expression and localization of AE1 protein in tumor cells inter-
rupt the physiological function of AE2 protein and thereby
Figure 1. Cytoplasmic expression of AE1 and p16. (A) The expression of AE1, AE2, and p16 in tumor cell lines was identified by Western blot analysis. AE2 was
expressed in all cells as indicated. Positive staining of AE1 and p16 was observed in MKN45 and SW1116 cells. (B) The proportion of p16 in the nucleus and
cytoplasm of MKN45 and SW1116 cells was identified, and the cytoplasmic distribution of p16 was dramatically observed. W, whole-cell extract; C, cytoplasmic
fraction; N, nuclear fraction. (C) Immunochemistry of endogenous AE1 and AE2 in MKN45 (a) and SW1116 (c) cells. Secondary Texas red– or fluorescein
isothiocyanate– labeled antibodies were added to the samples before mounting the coverslips on slides. Blue: Nuclear staining of the cells (b to a; d to c). (D) The
expression of AE1 and p16 in human gastric adenocarcinoma tissues. Sample slices were probed with primary anti-AE1 or anti-p16 antibodies. (a) Negative
staining of AE1 in noncancer tissue. (b) Nuclear staining of p16 in noncancer tissue (brown). (c) Cytoplasmic staining of AE1 in gastric adenocarcinoma (brown). (d)
Cytoplasmic expression of p16 in gastric adenocarcinoma (brown).
Table 1. Correlation of AE1 and p16 Expressions in Gastric and Colonic
Adenocarcinoma.
Grade Gastric Adenocarcinoma*
(n = 55)
Colonic Adenocarcinomay
(n = 15)
AE1 (%) p16 (%) AE1(%) p16 (%)
1 30.3 27.3 54.5 45.5
2 36.4 30.3 27.3 27.3
3 18.2 24.2 0 9.0
4 15.1 18.2 18.2 18.2
Grade 1, mild; grade 2, moderate; grade 3, abundant; grade 4, strongly abundant.
*r = 0.93.
yr = 0.99 (AE1 vs p16 expression).
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change the intracellular pH (pHi) of the tumor cells. To test
this hypothesis, the pHi of single MKN45 or SW1116 cells
was recorded by spectrofluorimetric monitoring with the pH-
sensitive fluorescent dye BCECF, using an Electrophysiol-
ogy Analysis System (ORCA AG; Hamamatsu, Japan). The
resting pHi is higher than that of the cell that did not express
AE1 (data not shown), suggesting that the regulation of pHi
is abnormal in the two tumor cells. This result raised the
question as to whether the cytoplasmic distribution of p16
protein was induced by an elevated pHi. To determine whether
the aberrant p16 distribution in cellular subfractions was pH-
dependent, the two tumor cells were cultured in a low-pH
medium (pH stable at 6.0), the cells were harvested, and
nuclear–cytoplasmic fractionation was performed after the
culture for 12, 24, and 48 hours, respectively. The expression
of p16 in whole MKN45 cells was upregulated at 12 and
24 hours, but was downregulated at 48 hours after the culture
pH was decreased from 7.4 to 6.0. Upregulation of p16 was
not observed in SW1116 cells (Figure 3A, upper panel ).
The movement of p16 from the cytoplasm to the nucleus
was not visualized by dynamic detection of p16 expression in
the nucleus of MKN45 and SW1116 cells (Figure 3A, lower
panel ). This was further confirmed by comparing the expres-
sion of p16 protein in the nucleus and cytoplasm in the same
sample (Figure 3B). The results demonstrated that the distri-
bution of p16 in cellular subfractions is not pH-dependent,
despite the possibility that aberrant AE1 expression may be
responsible for the elevated pHi in the two tumor cells.
siRNA-Mediated Silencing of AE1 in the Cells Induced p16
Release from the Cytoplasm to the Nucleus
To better understand the relationship between AE1 and
p16, we detected the expression of AE1 and the cytoplasmic
distribution of p16 in the three other gastric adenocarcinoma
cell lines, MKN28 (well-differentiated), AGS (moderately dif-
ferentiated), and SGC7901 (poorly differentiated). AGS and
SGC7901 cells expressed AE1 and cytoplasmic p16, where-
as neither AE1 nor p16 was expressed in MKN28 cells. Nev-
ertheless, all cell lines normally expressed AE2 (Figure 3, C
and D).
Taken together, the results demonstrate that AE1 is
the factor responsible for p16 cytoplasmic sequestration.
Figure 2. AE1 and p16 interaction. Whole-cell lysates from MKN45 or
SW1116 cells were immunoprecipitated with mouse anti-human AE1 or rabbit
anti-human p16 antibodies, followed by immunoblotting for associated p16
(A) or AE1 (B) antibodies. Mouse and rabbit preimmune sera were used as
negative controls.
Figure 3. The cytoplasmic distribution of p16 in MKN45 and SW1116 cells was not affected by the low pH of the culture, and expression occurred in the three other
gastric adenocarcinoma cell lines. (A) p16 expression in whole-cell extract (upper panel) and nucleus (lower panel) from two tumor cell lines cultured at pH 6.0 (for
12, 24, and 48 hours) and pH 7.4. (B) Direct comparison of the nuclear –cytoplasmic distribution of p16 in the two tumor cell lines cultured at pH 6.0 and 7.4. (C)
The expression of AE1 and AE2 in the three other gastric adenocarcinoma cell lines. (D) Cytoplasmic distribution of p16 in the three other gastric adenocarcinoma
cell lines. W, whole-cell extract; C, cytoplasmic fraction; N, nuclear fraction. MKN28, AGS, and SGC7901 represent well, moderately, and poorly differentiated
gastric adenocarcinoma cell lines, respectively.
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We suppose that overexpression of AE1 could sequester
more p16 in the cytoplasm and, conversely, blocking the
expression of AE1 in these cells could lead to the release of
p16 from the cytoplasm to the nucleus. We therefore trans-
fected AE1 constructs into AGS and SW1116 cells. The re-
sults showed that the level of p16 expression in whole-cell
lysates of the two tumor cells was not regulated by forced
expression of AE1 (Figures 4A and 5A). However, cytoplas-
mic p16 was upregulated in a time-dependent manner along
with the expression of AE1 (Figures 4B and 5B, lower panel )
compared with empty vector transfection (Figures 4B and 5B,
upper panel ), indicating that overexpression of AE1 in the two
tumor cells sequestered more p16 in the cytoplasm.
Next, we attempted to block the expression of the AE1
gene in AGS and SW1116 cells by siRNA. Three single-
stranded DNA 64-mer oligonucleotides (containing P1, P2,
and P3 sequences) were selected based on an analysis of
the open reading frame using an siRNA design software
(www.ambion.com). To determine the most efficient siRNA
sequences, the constructs were transiently transfected into
the two tumor cells to reduce the expression of AE1. Fig-
ures 4C and 5C show that only the P2 construct had the effi-
ciency to block the expression of AE1 in both AGS and
SW1116 cells. Therefore, we selected the P2 construct to
transfect the AGS and SW1116 cells. Notably, transfection
with the P2 construct resulted in the accumulation of p16 in
Figure 4. Forced expression or knockdown of AE1 in AGS cells. (A) Forced expression of AE1 in AGS cells at 0 to 72 hours posttransfection of the pcDNA3-AE1
construct. The expression of endogenous p16 in whole-cell lysates was synchronously detected as indicated. (B) Cytoplasmic sequestration of p16 in AGS cells
transfected with pcDNA3-AE1 (lower panel), compared with the transfection of an empty vector (upper panel). C, cytoplasmic fraction; N, nuclear fraction. (C) The
expression of endogenous AE1 in AGS cells transiently transfected with P1-pSilencer, P2-pSilencer, and P3-pSilencer 3.1-H1 neo constructs for 48 hours; AE1
was detected by immunoblots. (D) Movement of p16 from the cytoplasm to the nucleus after the transfection of P2-pSilencer 3.1-H1 neo constructs.
Figure 5. Forced expression or blockage of AE1 in SW1116 cells. The experimental design was the same as that in Figure 4.
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the nucleus and a remarkable decrease in the cytoplasm in
the two cells (Figures 4D and 5D).
To determine whether siRNA-mediated AE1 silencing in
AGS and SW1116 cells had an intrinsic effect on cell growth,
stable-transfected mono cells were selected with the infi-
nite dilution method in 96-well plates and counted on day 17
(the cells were expanded from a single clone) and day 25
(1000 cells from a single clone were continually expanded for
another 8 days). The growth of P2 vector–transfected AGS
and SW1116 transfectants was remarkably inhibited, com-
pared with the scrambled vector– transfected AGS and
SW1116 transfectants, as indicated in Figure 6A. After cul-
ture for another 8 days, the alive P2 vector–transfected AGS
and SW1116 cells were not detected. Morphologic fea-
tures were shown to be different between the P2 vector–
transfected and the scrambled vector–transfected AGS and
SW1116 transfectants (Figure 6B ).
Discussion
We have reported herein, for the first time, the coexpression
of AE1 and AE2 in gastric and colonic tumor cells. The ex-
pressed AE1 protein did not localize to the plasma mem-
brane, suggesting that the cells do not have the ability for
AE1 membrane traffic or that AE1 lacks the ability to traffic to
the plasma membrane even if it has a normal amino acid
sequence. We propose that the aberrant expression and
storage of AE1 in the cytoplasm interrupt the well-balanced
mechanism for maintaining natural pHi in normal cells.
Physiological anion exchange by AE2 usually represents
chloride uptake in exchange for bicarbonate efflux [19,20].
Therefore, the alkalization of gastric and colonic cancer cells,
which aberrantly express AE1, implies the dysfunction of
AE2 protein. However, decreasing the pH to 6.0 in culture
media without a resulting p16 return to the nucleus indicates
that cellular alkalization is not responsible for the cytoplasmic
Figure 6. AE1 knockdown induced cell death and growth inhibition in AGS and SW1116 cells. (A) AGS and SW1116 cells were stably transfected with P2-
pSilencer or scrambled-pSilencer 3.1-H1 neo constructs, respectively. After selection by G418, 12 single clones of P2 vector or scrambled vector transfectants—
numbered 3, 22, and 36 (AGS; scrambled vector transfectants); 7, 8, and 47 (AGS; P2 vector transfectants); 2, 5, and 7 (SW1116; scrambled vector transfectants);
and 1, 4, and 6 (SW1116; P2 vector transfectants)—were isolated and expanded in 96-well plates. Viable cells were counted after 17 days. One thousand cells
were then isolated from the same clones and expanded for another 8 days (total, 25 days), and the cells were counted. *Number of cells, < 104. **Number of cells,
0. (B) Another six clones of P2 vector or scrambled vector transfectants of AGS and SW1116 were isolated and expanded. The cell deaths of the P2 vector AGS (a)
and SW1116 (c) transfectants or scrambled vector AGS (b) and SW1116 (d) transfectants were observed. The morphologic features of the P2 vector AGS (e) and
SW1116 (g) transfectants or the scrambled vector AGS (f) and SW1116 (h) transfectants were examined under a microscope following Wright’s staining of the cells.
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distribution of p16. Co-IP of the two proteins in the tumor
cells demonstrated the interaction of AE1 and p16, support-
ing the structural sequestration of p16 by AE1.
Two isoforms of AE proteins are found in gastrointestinal
tumor cells, which could raise a question on the posteffect of
aberrant AE1 through the p16 pathway. It is known that p16
protein acts as a cell-cycle suppressor in the nucleus and
that its biologic function has been extensively described in
the past decade; however, there are still some unresolved
and controversial issues [21]. Recent studies have described
the cytoplasmic localization of p16 that differs from the
current view concerning p16 immunohistochemical localiza-
tion. The described protein accumulation is apparently not
caused by an alteration of the p16 gene [22]. Electron mi-
croscopy has also provided evidence that the cytoplasmic
localization of p16 in non–small cell lung cancer is specific
[23]. However, insufficient attention has been paid to the
basis for immunohistochemical signals. In the present article,
we demonstrated that p16 was frequently expressed in the
cytoplasm and that cytoplasmic existence in most gastric
and colonic cancers is closely related to aberrant cytoplas-
mic expression of AE1.
Gastric cancer is the fourth most common cancer world-
wide [24]. The most common type of gastric cancer is ade-
nocarcinoma, which starts in the glandular tissue of the
stomach and accounts for 90% to 95% of all gastric cancers.
Many genes have been analyzed to understand the molec-
ular bases for human gastric cancers, but only a few with
frequent alterations have been identified [25–27]. This ge-
netic research uncovers a more complete understanding of
gastric cancer and allows for the development of specific
therapy for specifically abnormal proteins. In addition, co-
lonic cancer results from the progressive accumulation of
genetic and epigenetic alterations that lead to the transfor-
mation of normal colonic epithelial cells into colon adeno-
carcinoma cells [28]. Although some genes associated with
colon cancer have now been identified and genetic testing is
available for diagnosis [29–31], the use of genetic/molecular
markers, together with new targeted therapies, remains to
be investigated.
The abnormality of p16 is frequently reported in both gas-
tric and colonic cancers or neoplasms [32]. The major mech-
anism for p16 dysfunction results from the hypermethylation
of its promoter or gene mutations [33]. Our results provide
a novel pathway for the dysfunction of p16 in gastric and
colonic cancers, in which p16 is expressed but is seques-
tered in the cytoplasm by aberrant expression of AE1. The
discovery of the cause and specific effect of the cytoplasmic
distribution of p16 in gastric and colonic cancers will yield
more effective chemotherapy strategies that take advantage
of this unique characteristic of cancer cells and provide the
potential to further improve survival.
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